Hospital Antibiotic Policies Improve Prescription Practices
|
By HospiMedica International staff writers Posted on 21 Feb 2017 |
An updated review of studies identifies effective guidelines and policies to reduce unnecessary use of antibiotics in hospitals.
Researchers at the University of Dundee, University College London, and other institutions searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and Embase for studies examining the effectiveness and safety of interventions designed to improve antibiotic prescribing to hospital inpatients, and to investigate the effect of different intervention functions. In all, the researchers found 221 studies from the United States, Europe, Asia, South America, and Australia.
The researchers found that interventions broadly fell into two categories; 'restrictive' techniques applied rules to make physicians prescribe properly, whilst 'enabling' techniques provided advice or feedback to help physicians make more informed prescribing decisions. In both cases, the aim of the intervention was to increase the number of appropriate prescribing decisions so that patients who were unlikely to benefit from antibiotics did not get them, whilst they were still used for patients who stood to benefit from them.
The results showed that interventions that included enabling or restrictive techniques were consistently more effective than interventions that relied on simple education alone. Moreover, a synergistic effect existed, with enabling techniques increasing the effectiveness of restrictive techniques. In addition, the interventions shortened duration of antibiotic use from 11 to 9 days per patient, and reduced hospital stay from an average of 13 days to 12 per patient. The review was published on February 9, 2017, in The Cochrane Library.
“We do not need more studies to answer the question of whether these interventions reduce unnecessary antibiotic use, but we do need more research to understand why the most effective behavior change techniques are not more widely adopted within hospital settings,” concluded lead author Peter Davey, PhD, of the UD department of population health sciences. “Appropriate antibiotic use in hospitals should ensure effective treatment of patients with infection, and reduce unnecessary prescriptions.”
For the study, the researchers defined restriction as using rules to reduce the opportunity to engage in the target behavior, or increase the target behavior by reducing the opportunity to engage in competing behaviors. Enablement was defined as increasing the means and reducing the barriers in order to increase capability or opportunity.
Researchers at the University of Dundee, University College London, and other institutions searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and Embase for studies examining the effectiveness and safety of interventions designed to improve antibiotic prescribing to hospital inpatients, and to investigate the effect of different intervention functions. In all, the researchers found 221 studies from the United States, Europe, Asia, South America, and Australia.
The researchers found that interventions broadly fell into two categories; 'restrictive' techniques applied rules to make physicians prescribe properly, whilst 'enabling' techniques provided advice or feedback to help physicians make more informed prescribing decisions. In both cases, the aim of the intervention was to increase the number of appropriate prescribing decisions so that patients who were unlikely to benefit from antibiotics did not get them, whilst they were still used for patients who stood to benefit from them.
The results showed that interventions that included enabling or restrictive techniques were consistently more effective than interventions that relied on simple education alone. Moreover, a synergistic effect existed, with enabling techniques increasing the effectiveness of restrictive techniques. In addition, the interventions shortened duration of antibiotic use from 11 to 9 days per patient, and reduced hospital stay from an average of 13 days to 12 per patient. The review was published on February 9, 2017, in The Cochrane Library.
“We do not need more studies to answer the question of whether these interventions reduce unnecessary antibiotic use, but we do need more research to understand why the most effective behavior change techniques are not more widely adopted within hospital settings,” concluded lead author Peter Davey, PhD, of the UD department of population health sciences. “Appropriate antibiotic use in hospitals should ensure effective treatment of patients with infection, and reduce unnecessary prescriptions.”
For the study, the researchers defined restriction as using rules to reduce the opportunity to engage in the target behavior, or increase the target behavior by reducing the opportunity to engage in competing behaviors. Enablement was defined as increasing the means and reducing the barriers in order to increase capability or opportunity.
Latest Hospital News News
- Nurse Tracking System Improves Hospital Workflow
- New Children’s Hospital Transforms California Healthcare
- Noisy Hospitals Face Threat of Decreased Federal Compensation
- Orthopedics Centre of Excellence Planned for Guy’s Hospital
- Research Suggests Avoidance of Low-Value Surgical Procedures
- U.S. Federal Readmission Fines Linked to Higher Mortality
- Columbia China to Build New Hospital in Jiaxing
- Dubai Debuts Second Robotic Pharmacy Service
- Seattle Hospital Network Shifts Away from Overlapping Surgeries
- ACC to Launch Valvular Heart Disease Program in China
- Mortality Rates Lower at Major Teaching Hospitals
- South Australia to Inaugurate Upscale Hospital
- Raffles to Launch Second Hospital Project in China
- Research Center Tackles Antimicrobial Drugs Challenge
- Miami Cardiac & Vascular Institute Completes Expansion Project
- USC Virtual Care Clinic to Employ Avatar Doctors
Channels
Artificial Intelligence
view channel
Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening
Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. Providers and trial... Read more
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read moreCritical Care
view channel
Reusable Intermittent Catheters Reduce Antibiotic Use Without Increasing Urinary Tract Infections
Intermittent self-catheterization, used to empty the bladder several times a day, can leave patients vulnerable to recurrent urinary tract infections and repeated antibiotic use. Reliance on single-use... Read more
Implantable Wireless Light Device Advances Bladder Cancer Treatment
Bladder cancer, a malignancy of the urinary bladder, often requires local therapies that spare surrounding tissue. Photodynamic therapy uses light-activated drugs but is limited by poor light penetration... Read moreSurgical Techniques
view channel
Anesthesia-Sparing System Targets Faster Ureteral Stone Treatment
Ureteral stone care is often delayed by operating room scheduling constraints and growing wait times, leaving a gap between diagnosis and treatment. With no fundamentally new therapeutic approach introduced... Read more
BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures
BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read morePoint of Care
view channel







